Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease.
about
Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@en
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@nl
type
label
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@en
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@nl
prefLabel
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@en
Unanticipated increases in hep ...... alcoholic fatty liver disease.
@nl
P2093
P50
P356
P1433
P1476
Unanticipated increases in hep ...... -alcoholic fatty liver disease
@en
P2093
Caryn G Morse
Chia-Ying Liu
Colleen Hadigan
Julia B Purdy
P304
P356
10.1111/LIV.13734
P577
2018-03-31T00:00:00Z